Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 5Sarcoma 2Radiation Injuries 2Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Multiple Myeloma 2Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma 1Lymphedema 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Laryngeal Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Flap Necrosis 1Fibrosis 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Cyclophosphamide 444Rituximab 401Etoposide 224Vincristine 215Doxorubicin 201Filgrastim 200Prednisone 176Cytarabine 159Radiotherapy 152fludarabine phosphate 147Methotrexate 137Peripheral Blood Stem Cell Transplantation 129Melphalan 127fludarabine 115Busulfan 99Dexamethasone 93Tacrolimus 75Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 71Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 62Cyclosporine 62Bendamustine Hydrochloride 62Lenalidomide 60Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma × Hyperbaric Oxygenation × Clear all
NCT02682953 2019-12-11

Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers

University of Maryland, Baltimore

Phase 2 Withdrawn
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡